In questo podcast vi porteremo a scoprire la terribile patologia dell’ebola, i sintomi e la sua diffusione; vi parleremo anche dei due vaccini approvati e in uso che hanno salvato la situazione e delle prospettive future. 

Podcast a cura di: Busetto Rebecca, Franzin Elisa, Piana Monica

Bibliografia e Sitografia:

•       https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996233/

•       https://www.nature.com/articles/s41598-021-86688-z

•       https://www.ema.europa.eu/en/documents/product-information/ervebo-epar-product-information_en.pdf

•       https://www.cdc.gov/vhf/ebola/clinicians/vaccine/index.html

•        https://www.mesvaccins.net/web/vaccines/586-ervebo#vaccin_description

•       https://www.fda.gov/media/133748/download

•       https://www.ema.europa.eu/en/documents/assessment-report/ervebo-epar-public-assessment-report_en.pdf

•       https://www.nature.com/articles/nm1258

•       https://www.ema.europa.eu/en/documents/assessment-report/zabdeno-epar-public-assessment-report_en.pdf

•       https://www.ema.europa.eu/en/documents/assessment-report/mvabea-epar-public-assessment-report_en.pdf

•       https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_001306_048914_FI.pdf&retry=0&sys=m0b1l3

•       https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659338/

•       https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003865

•       https://clinicaltrials.gov/ct2/show/NCT02564523

•       https://www.cdc.gov/vhf/ebola/pdf/Ebola-Vaccine-Protocol_508.pdf

•       https://www.msdmanuals.com/it-it/professionale/malattie-infettive/vaccinazione/vaccino-ebola

•        E. I. Ohimain, “Recent advances in the development of vaccines for Ebola virus disease,” Virus Res., vol. 211, pp. 174–185, Jan. 2016, doi: 10.1016/J.VIRUSRES.2015.10.021.

•       L. Baseler, D. S. Chertow, K. M. Johnson, H. Feldmann, and D. M. Morens, “The Pathogenesis of Ebola Virus Disease*,” https://doi.org/10.1146/annurev-pathol-052016-100506, vol. 12, pp. 387–418, Jan. 2017, doi: 10.1146/ANNUREV-PATHOL-052016-100506.

•       R. Siddiqui, S. Khan, and N. A. Khan, “Ebola virus disease: Current perception of clinical features, diagnosis, pathogenesis, and therapeutics,” Acta Virol., vol. 65, no. 4, pp. 350–364, 2021, doi: 10.4149/AV_2021_409.

•       Y. Wang, J. Li, Y. Hu, Q. Liang, M. Wei, and F. Zhu, “Ebola vaccines in clinical trial: The promising candidates,” Hum. Vaccin. Immunother., vol. 13, no. 1, p. 153, Jan. 2017, doi: 10.1080/21645515.2016.1225637.

•       C. Woolsey and T. W. Geisbert, “Current state of Ebola virus vaccines: A snapshot,” PLoS Pathog., vol. 17, no. 12, Dec. 2021, doi: 10.1371/JOURNAL.PPAT.1010078.

•       S. T. Jacob et al., “Ebola virus disease,” Nat. Rev. Dis. Prim., vol. 6, no. 1, Dec. 2020, doi: 10.1038/S41572-020-0147-3.

•       “History of Ebola Virus Disease (EVD) Outbreaks | History | Ebola (Ebola Virus Disease) | CDC.” https://www.cdc.gov/vhf/ebola/history/chronology.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvhf%2Febola%2Foutbreaks%2Fhistory%2Fchronology.html (accessed Dec. 02, 2022).

•       L. Baseler, D. S. Chertow, K. M. Johnson, H. Feldmann, and D. M. Morens, “The Pathogenesis of Ebola Virus Disease,” Annu. Rev. Pathol., vol. 12, pp. 387–418, Jan. 2017, doi: 10.1146/ANNUREV-PATHOL-052016-100506.

•       S. T. Jacob et al., “Ebola virus disease,” Nat. Rev. Dis. Prim., vol. 6, no. 1, Dec. 2020, doi: 10.1038/S41572-020-0147-3.